Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
IDEAYA Biosciences, Inc. (NASDAQ: IDYA)
IDYA Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
285.30%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
90.10%
IDYA Stock Analysis
IDYA
PE Ratio:
IDYA
PEG Ratio:
Not Available
IDYA
Forward EPS Growth (12 month):
0.00%
IDYA
PS Ratio:
11.1
IDYA
PSG Ratio:
IDYA
Forward Revenue Growth (12 month):
310.20%
IDYA Articles
No data was found